Preventive Medicine: The American Board of Preventive Medicine (ABPM) defines the discipline as "that specialty of medical practice which focuses on the health of individuals and defined populations in order to
protect, promote, and maintain health and well-being and prevent disease, disability, and premature death."
The aim of preventive medicine is the absence of disease, either by preventing the occurrence of a disease or by halting a disease and averting resulting complications after its onset. Clinicians who work in clinical Preventive
Medicine see patients on a daily basis and may provide services in screening, health counseling, and immunization. This can include people with diabetes, smokers, cardiac patients, and others who can benefit from prevention and
Lifestyle Medicine: Defined in the Journal of the American Medical Association as the “evidence-based practice of assisting individuals and their families to adopt and sustain behaviors that can improve health and quality of life." Similar to preventive medicine, lifestyle medicine is recommended as a foundational approach to preventing and treating many chronic diseases.
Patient-Centered Outcomes Research (PCOR)
PCOR compares the impact of different treatments and interventions on health outcomes to provide evidence on which strategies are most effective in different populations and situations.
Medi-Weightloss® conducts PCOR which focuses on outcomes important to patients’ health and their quality of life, and provides evidence-based treatment options to patients. The company conducts prospective and retrospective studies to evaluate the impact of weight loss interventions on health outcomes.
The adverse health consequences of obesity are well known and include increasing one’s risk of developing high blood pressure, heart disease, and diabetes. It has been shown that weight loss can improve these conditions, and perhaps more importantly, help to prevent the development of these diseases. Typically, these conditions develop slowly over time, with little to no signs or symptoms early in the process. Therefore early diagnosis and effective interventions can result in tremendous long-term benefits.
MediLiving® strives to be the industry leader in Preventive Medicine and Obesity Medicine. Our clinical research team led by Macklin Guzman, DHSc, MPH, is our commitment to making advances in all of these areas, allowing our healthcare professionals to implement these advances in our programs. Our counseling methods are researched and validated to produce clinically relevant results that have measurable improvements in our patients' health.
The purpose of the Scientific Advisory Board is to critically review the effectiveness, safety, and added value of the MediLiving® treatment guidelines and products through outcomes research. The initiatives of this interdisciplinary team are shaped by the company’s dedication to quality assurance and the timely integration of clinical research findings into patient care. These efforts help assure that MediLiving® is and will always be the leader in Preventive Medicine! Click here to learn more about our Scientific Advisory Board.
Source: Cardio Smart www.cardiosmart.com
Prediabetes is a term used to describe individuals who have blood glucose levels that are just under the range of a type 2 diabetes diagnosis. These individuals are at high risk of developing type 2 diabetes and are susceptible to diabetes-related health complications, including stroke and cardiovascular disease.
Most people with prediabetes do not have symptoms. In fact, millions of people have it and don’t know it. Symptoms of diabetes include:
If you are overweight or suffer from any of the mentioned symptoms, a simple test that measures your hemoglobin A1C level can determine whether you have prediabetes. This convenient test does not require fasting and can be done at any participating Medi-Weightloss® location.